Carcinoma Micromets
Also known as: Carcinoma micrometastases
Use
Detection of small groups of metastatic carcinoma cells (micrometastases) in sentinel lymph nodes via immunohistochemistry serves as an important prognostic indicator, as it may represent the earliest evidence of cancer spread that is not easily identifiable by routine histologic H&E evaluation.
Special Instructions
Tissue block identifiers must be clearly written and match exactly the specimen ID and labeling on the requisition. Use a cold pack for transport, ensuring it does not directly contact the specimen. For New York State clients, provide the date and time of specimen collection.
Limitations
Not provided.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
24 hours
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Block identifiers should be clearly written and match exactly with the specimen ID and specimen labeling as noted on the requisition.
Storage Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.